Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner

Por Chen, Minghui, Wang, Xueshi, Zha, Daolong, Cai, Fangfang, Zhang, Wenjing, He, Yan, Huang, Qilai, Zhuang, Hongqin, Hua, Zi-Chun
Publicado no Sci Rep (2016)

Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-κB pathway

Por Chen, Minghui, Cai, Fangfang, Zha, Daolong, Wang, Xueshi, Zhang, Wenjing, He, Yan, Huang, Qilai, Zhuang, Hongqin, Hua, Zi-Chun
Publicado no Oncotarget (2017)

Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer

Por Cai, Fangfang, Chen, Minghui, Zha, Daolong, Zhang, Peng, Zhang, Xiangyu, Cao, Nini, Wang, Jishuang, He, Yan, Fan, Xinxin, Zhang, Wenjing, Fu, Zhongping, Lai, Yueyang, Hua, Zi-Chun, Zhuang, Hongqin
Publicado no Oncotarget (2017)

FADD is a key regulator of lipid metabolism

Por Zhuang, Hongqin, Wang, Xueshi, Zha, Daolong, Gan, Ziyi, Cai, Fangfang, Du, Pan, Yang, Yunwen, Yang, Bingya, Zhang, Xiangyu, Yao, Chun, Zhou, Yuqiang, Jiang, Chizhou, Guan, Shengwen, Zhang, Xuerui, Zhang, Jing, Jiang, Wenhui, Hu, Qingang, Hua, Zi‐Chun
Publicado no EMBO Mol Med (2016)